Literature DB >> 19801160

Isochromosome 12p and polysomy 12 in primary central nervous system germ cell tumors: frequency and association with clinicopathologic features.

William R Sukov1, John C Cheville, Caterina Giannini, Austin W Carlson, Brandon M Shearer, Jason P Sinnwell, Rhett P Ketterling.   

Abstract

Germ cell tumors arising within the central nervous system are rare neoplasms that typically occur along midline structures in children and young adults. Although isochromosome 12p is established as a frequent chromosomal abnormality in testicular germ cell tumors, studies examining isochromosome 12p in primary central nervous system germ cell tumors are limited. Herein, we studied 24 primary central nervous system germ cell tumors from 23 patients using fluorescence in situ hybridization to determine the frequency of isochromosome 12p in these neoplasms. Of the 24 primary central nervous system germ cell tumors, fluorescence in situ hybridization detected isochromosome 12p in 6 (25%) tumors, whereas 11 (46%) tumors showed polysomy (multiple copies) of chromosome 12. One case with isochromosome 12p also showed increased 12p independent of isochromosome 12p formation. The remaining 7 tumors yielded a normal result by fluorescence in situ hybridization. Clinical follow-up of this patient cohort indicated 8 patients (32%) developed a recurrence, although no association was demonstrated between the presence or absence of chromosomal 12 abnormalities and tumor relapse. We confirm that isochromosome 12p is less frequent in primary central nervous system germ cell tumors relative to testicular germ cell tumors, and although our numbers are limited, the presence or absence of isochromosome 12p does not appear to impact tumor recurrence. Similarly, although polysomy 12 was identified in nearly half of our central nervous system germ cell tumors, no prognostic significance was attributed to this abnormality. These results suggest that fluorescence in situ hybridization studies for isochromosome 12p or polysomy 12 may have limited use in the evaluation of these rare neoplasms. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19801160     DOI: 10.1016/j.humpath.2009.07.017

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.

Authors:  Kaishi Satomi; Hirokazu Takami; Shintaro Fukushima; Satoshi Yamashita; Yuko Matsushita; Yoichi Nakazato; Tomonari Suzuki; Shota Tanaka; Akitake Mukasa; Nobuhito Saito; Masayuki Kanamori; Toshihiro Kumabe; Teiji Tominaga; Keiichi Kobayashi; Motoo Nagane; Toshihiko Iuchi; Koji Yoshimoto; Kaoru Tamura; Taketoshi Maehara; Keiichi Sakai; Kazuhiko Sugiyama; Kiyotaka Yokogami; Hideo Takeshima; Masahiro Nonaka; Akio Asai; Toshikazu Ushijima; Masao Matsutani; Ryo Nishikawa; Koichi Ichimura
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

2.  A Novel Germline SDHA Gene Mutation and Co-Occurring Somatic KIT Activating Mutation in a Patient With Pediatric Central Nervous System Germ Cell Tumor: Case Report.

Authors:  Xizan Yue; Bo Liu; Tiantian Han; Ningning Luo; Guanghua Lu; Didi Guo; Fanfeng Bu; Guangyu Wang
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

Review 3.  Molecular markers in pediatric neuro-oncology.

Authors:  Koichi Ichimura; Ryo Nishikawa; Masao Matsutani
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

4.  Yolk sac tumor differentiation in urothelial carcinoma of the urinary bladder: a case report and differential diagnosis.

Authors:  Nadia Espejo-Herrera; Enric Condom-Mundó
Journal:  Diagn Pathol       Date:  2020-06-03       Impact factor: 2.644

Review 5.  Intracranial Germ Cell Tumor in the Molecular Era.

Authors:  Ji Hoon Phi; Kyu-Chang Wang; Seung-Ki Kim
Journal:  J Korean Neurosurg Soc       Date:  2018-05-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.